The enzymatic carboligation of aldehydes (C–C bond formation) catalyzed by benzaldehyde lyase (BAL) affords chiral α-hydroxy-ketones under mild reaction conditions in aqueous media. To enhance substrate and product availability under aqueous conditions, processes are often set-up using either DMSO as co-solvent, or MTBE as second organic phase. Although efficient, DMSO leads to difficulties in separation during downstream processing, with wastewater formation. MTBE provides a cleaner and straightforward work-up, but its petrochemical origin, together with its poor degradability, gives rise to environmental concerns. Herein it is reported that 2-methyltetrahydrofuran (2-MTHF) is a promising candidate to substitute DMSO or MTBE in lyase-catalyzed reactions. 2-MTHF can be derived from bio-based resources (e.g. levulinic acid), and it is abiotically degraded by air. When BAL is added to buffer-2-MTHF (5% v/v) mixtures, enzyme remains stable with a half-life of 178 ± 8 h, with productivities (benzoin synthesis) of 10 g benzoin L−1h−1. Several BAL-catalyzed aldehyde carboligations were assessed under those conditions, leading in all cases to high isolated yield (quantitative in majority), and to high enantioselectivity (up to >99%). Furthermore, preliminary results obtained with two phase systems in the BAL-catalyzed benzoin synthesis afforded 60 g benzoin L−1 in 24 h (ee > 99%). Therefore, 2-MTHF may be a valuable (co)solvent, not only to tackle environmental concerns, but also in terms of practical, efficient biocatalysis.
No takes yet. Share an insight, caveat, or question.
Shanmuganathan et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: